Kadcyla, a drug that can offer some women with advanced breast cancer nearly six months of extra life, which was trialled here in the North East, has for now been rejected for use in the NHS, because of its high cost.
A Newcastle doctor whose patients have been involved in the clinical trials is disappointed by the decision.
Dr Mark Verrill, from the Freeman Hospital, say the drug is revolutionary.
More top news
Newcastle midfielder Sammy Ameobi has joined Cardiff on a season-long loan deal after signing a new two-year contract at St James' Park.
A look ahead at the forecast for the Tyne Tees region.
Some Muslims living in our region say the 7/7 atrocities caused some to be demonised.